JAGX / Jaguar Health, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Jaguar Health, Inc.

Azioni in circolazione 2,174,841 shares
Azioni degli insider1.489.428 shares
Proprietà degli insider68,48 %
Numero totale di insider33
Indice del sentiment degli insider

L'indice del sentiment degli insider identifica le società le cui azioni vengono acquistate dagli insider aziendali.

È il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di insider. Il modello di punteggio utilizza una combinazione del numero netto di acquisti degli insider negli ultimi 90 giorni, delle azioni totali acquistate in percentuale del flottante e delle azioni totali possedute dagli insider. Il punteggio varia da 0 a 100: i numeri più alti indicano un livello di accumulo superiore ad altre società, mentre 50 rappresenta la media.

Frequenza di aggiornamento: giornaliera

Vedi I preferiti degli insider, per accedere all'elenco delle società con il più alto accumulo di insider.

Indice del sentiment dei dirigenti

L'indice del sentiment dei dirigenti identifica le società le cui azioni vengono acquistate dai dirigenti aziendali.

Per definizione, i dirigenti aziendali sono insider della società, ma a differenza di altri insider (azionisti al 10% e membri del consiglio di amministrazione), i dirigenti lavorano quotidianamente per la società e utilizzano il proprio denaro quando fanno trading (gli azionisti al 10% e i membri del consiglio di amministrazione sono spesso gestori di fondi che gestiscono il denaro di altre persone). Pertanto, le operazioni di insider trading effettuate dai dirigenti sono molto più significative e devono essere trattate in modo appropriato.

Come l'indice del sentiment degli insider, l'indice del sentiment dei dirigenti è il risultato di un sofisticato modello quantitativo multi-fattore che identifica le società con i più alti livelli di accumulo di dirigenti.

Frequenza di aggiornamento: giornaliera

Vedi I preferiti degli insider, per accedere all'elenco delle società con il più alto sentiment degli insider.

Principali indicatori per gli insider

Questa scheda mostra il posizionamento della società in base a diversi indicatori di insider. Il grado percentile mostra come la società si colloca rispetto alle altre società dei mercati statunitensi. Posizioni più alte indicano situazioni migliori.

Ad esempio, è generalmente accettato che gli acquisti di insider siano un indicatore positivo, per cui le società con un maggior numero di acquisti di insider si classificherebbero più in alto rispetto a quelle con un minor numero di acquisti di insider (o addirittura di vendite di insider).

Numero netto di acquisti di insider (classifica)

0 ( )

5806 out of 11323

Il numero netto di acquisti di insider è il numero totale di acquisti di insider meno il numero totale di vendite di insider negli ultimi 90 giorni. Il grado percentile è mostrato qui (intervallo da 0 a 100%).

Percentuale del flottante acquistato dagli insider (classifica)

0.000 %( )

5754 out of 11244

La percentuale del flottante acquistato dagli insider è data dal numero totale di azioni acquistate dagli insider meno il numero totale di azioni vendute dagli insider negli ultimi 90 giorni, divisa per il flottante totale e moltiplicata per 100.

Grafico sull'insider trading

Il grafico seguente mostra le operazioni di insider trading di Jaguar Health, Inc.. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4.

Lista degli insider e indicatori di redditività

Questa tabella mostra la lista degli insider noti ed è generata automaticamente a partire dai depositi effettuati presso la SEC. Oltre ai nomi, al titolo più recente e alla designazione di amministratore, funzionario o proprietario al 10%, forniamo le ultime partecipazioni divulgate. Inoltre, quando possibile, forniamo la performance storica delle transazioni dell'insider. La performance storica delle transazioni è una media ponderata della performance delle operazioni di acquisto sul mercato aperto effettuate dall'insider. Per maggiori informazioni su come viene calcolata, guarda questo webinar su YouTube.

See our leaderboard of most profitable insider traders.

Insider Utile medio (%) Azioni
possedute
Rettificato
per il frazionamento azionario
Ari Azhir 39.286
James J Bochnowski Director - [D] 78.876 1.856
Bvcf Iii, L.p. 10% Owner - [10%] 1.522.881 36.844
Bvcf Iii-a, L.p. 10% Owner - [10%] 1.522.881 36.844
BVCF Management, Ltd. 10% Owner - [10%] 1.522.881 36.844
Philippe Brianceau 20.000
Bryan Ezralow 1994 Trust dated December 22, 1994 - 2.916.667 62.589
Capital Ltd Burford 10% Owner - [10%] 0 0
Lisa A Conte CEO and President, Director - [D] [O] 666 666
Pravin R Chaturvedi Chief Scientific Officer - [O] 4.957 198
Greg J Divis Director - [D] 12.133 227
Insider Utile medio (%) Azioni
possedute
Rettificato
per il frazionamento azionario
Bryan Ezralow 10% Owner - [10%] 2.916.667 62.589
Jonathan M Glaser - 720.405 15.459
Michael Hauser 73.000
Johnson Jeffery C. 121.573
Anula Jayasuriya Director - [D] 70.286 1.654
John A Kallassy 13.365
Kamphuis Folkert W. 53.164
King Steven R. See Remarks - [O] 145 145
Kunlun Pharmaceuticals, Ltd. 10% Owner - [10%] 1.522.881 36.844
Lincoln Alternative Strategies LLC 10% Owner - [10%] 1.200.000 1.200.000
Lizak Carol R. Chief Financial Officer - [O] 4.297 172
Insider Utile medio (%) Azioni
possedute
Rettificato
per il frazionamento azionario
John Micek Director - [D] 80.701 1.899
Murray David MacNaughtan 121.573
Napo Pharmaceuticals Inc 10% Owner - [10%] 5.333.332 129.032
Nantucket Investments Ltd 10% Owner - [10%] 0 0
Jiahao Qiu 12.965
Sagard Capital Partners, L.P. 5.524.926
Siegel Jonathan B. Director - [D] 69.874 1.644
Waltzman Roger J. 2.866
Wolin Jonathan S. See Remarks - [O] 4.955 198
Karen Steil Wright 303.932
Zhi Yang Director, 10% Owner - [D] [10%] 1.522.881 36.844

Report errors via our new Insider Auditing Tool

Storico degli acquisti di insider - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider effettuato sul mercato aperto in JAGX / Jaguar Health, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2022-12-31 Wolin Jonathan S. 317 0,0300 6 1,6000 10 11 519.75 2.590 28.775,00
2021-09-13 CONTE LISA A 7.968 2,5100 149 133,8667 20.000
2021-09-13 Lizak Carol R. 7.968 2,5100 149 133,8667 20.000
2019-07-23 BOCHNOWSKI JAMES J 180.582 2,0000 4.431 81,5000 361.164
2019-07-23 Siegel Jonathan B. 12.705 2,0000 312 81,5000 25.410

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.

JAGX / Jaguar Health, Inc. Insider Trades
Storico delle vendite di insider - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in JAGX / Jaguar Health, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici .

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
2021-06-04 BOCHNOWSKI JAMES J 152 1,7400 4 70,9050 264 364 1551.6 4.391 1.663,18
2021-06-03 BOCHNOWSKI JAMES J 292 1,7500 7 71,3125 511
2018-09-25 Nantucket Investments Ltd 325.615 1,8300 6.987 85,2780 595.875
2018-09-25 Nantucket Investments Ltd 270.270 1,8300 5.800 85,2780 494.594

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Le azioni rettificate sono le azioni rettificate per il frazionamento azionario.

JAGX / Jaguar Health, Inc. Insider Trades
Storico delle transazioni

Clicca sull'icona del link per visualizzare la cronologia completa delle transazioni. Le transazioni segnalate come parte di un piano di trading automatico 10b5-1 saranno contrassegnate con una X nella colonna contrassegnata con 10b-5.

Data di
deposito
Data dell'
operazione
Modulo Insider Ticker Titolo Codice 10b5-1 Diretto Prezzo
di esercizio
Prezzo
unitario
Unità
modificate
Valore
modificato (1K)
Opzioni
rimanenti
Azioni
rimanenti
2025-08-29 3 Lincoln Alternative Strategies LLC JAGX Common Stock, par value $0.0001 per share D 600.000
2025-05-20 2025-05-17 4 CONTE LISA A JAGX Common Stock M - Exercise D 2 666
2025-05-20 2025-05-17 4 King Steven R. JAGX Common Stock M - Exercise D 1 145
2024-10-10 2024-10-08 4 Lizak Carol R. JAGX Common Stock A - Award D 4.280 4.297
2024-10-10 2024-10-08 4 Wolin Jonathan S. JAGX Common Stock A - Award D 4.922 4.955
2024-10-10 2024-10-08 4 Chaturvedi Pravin R JAGX Common Stock A - Award D 4.922 4.957
2024-10-10 2024-10-08 4 CONTE LISA A JAGX Common Stock A - Award D 16.503 16.624
2024-10-10 2024-10-08 4 King Steven R. JAGX Common Stock A - Award D 4.922 4.951
2024-05-21 2024-05-17 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 871 2.012
2024-05-21 2024-05-17 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 871 2.141
2024-05-21 2024-05-17 4 Lizak Carol R. JAGX Common Stock M - Exercise D 431 1.042
2024-05-21 2024-05-17 4 King Steven R. JAGX Common Stock M - Exercise D 612 1.756
2024-05-21 2024-05-17 4 CONTE LISA A JAGX Common Stock M - Exercise D 2.695 7.295
2024-04-17 2024-04-05 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 134 1.270
2024-04-17 2024-04-05 4 Lizak Carol R. JAGX Common Stock M - Exercise D 60 611
2024-04-17 2024-04-05 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 89 1.141
2024-04-17 2024-04-05 4 King Steven R. JAGX Common Stock M - Exercise D 178 1.144
2024-04-17 2024-04-05 4 CONTE LISA A JAGX Common Stock M - Exercise D 600 4.600
2023-08-14 2023-08-14 4 Siegel Jonathan B. JAGX Common Stock A - Award D 68.568 69.874
2023-08-14 2023-08-14 4 MICEK JOHN JAGX Common Stock A - Award D 68.568 80.701
2023-08-14 2023-08-14 4 BOCHNOWSKI JAMES J JAGX Common Stock A - Award D 76.613 78.876
2023-08-14 2023-08-14 4 CONTE LISA A JAGX Common Stock A - Award D 383.605 387.605
2023-08-14 2023-08-14 4 King Steven R. JAGX Common Stock A - Award D 159.168 160.133
2023-08-14 2023-08-14 4 Lizak Carol R. JAGX Common Stock A - Award D 142.088 142.745
2023-08-14 2023-08-14 4 Wolin Jonathan S. JAGX Common Stock A - Award D 196.628 197.680
2023-08-14 2023-08-14 4 Jayasuriya Anula JAGX Common Stock A - Award D 68.568 70.286
2023-08-14 2023-07-01 4 Jayasuriya Anula JAGX Common Stock A - Award D 1.718 1.718
2023-08-14 2023-08-14 4 Chaturvedi Pravin R JAGX Common Stock A - Award D 204.192 205.328
2023-05-19 2023-05-17 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 870 1.136
2023-05-19 2023-04-05 4/A Chaturvedi Pravin R JAGX Common Stock M - Exercise D 133 266
2023-05-19 2022-04-05 4/A Chaturvedi Pravin R JAGX Common Stock M - Exercise D 10.000 10.000
2023-05-19 2023-05-17 4 MICEK JOHN JAGX Common Stock M - Exercise D 1.145 1.306
2023-05-19 2023-05-17 4 Siegel Jonathan B. JAGX Common Stock M - Exercise D 1.145 1.306
2023-05-19 2023-05-17 4 BOCHNOWSKI JAMES J JAGX Common Stock M - Exercise D 1.280 2.263
2023-05-19 2023-05-17 4 King Steven R. JAGX Common Stock M - Exercise D 611 965
2023-05-19 2023-05-17 4 Lizak Carol R. JAGX Common Stock M - Exercise D 431 657
2023-05-19 2023-05-17 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 871 1.052
2023-05-19 2023-05-17 4 CONTE LISA A JAGX Common Stock M - Exercise D 2.694 4.000
2023-04-20 2023-04-05 4 Lizak Carol R. JAGX Common Stock M - Exercise D 60 226
2023-04-20 2023-04-05 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 44 88
2023-04-20 2023-04-05 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 88 181
2023-04-20 2023-04-05 4 King Steven R. JAGX Common Stock M - Exercise D 177 354
2023-04-20 2023-04-05 4 CONTE LISA A JAGX Common Stock M - Exercise D 600 1.306
2023-01-03 2022-12-31 4 Wolin Jonathan S. JAGX Common Stock P - Purchase D 0,0300 317 0 6.983
2022-05-18 2022-05-18 4 BOCHNOWSKI JAMES J JAGX Restricted stock units M - Exercise D -13.133 0
2022-05-18 2022-05-18 4 BOCHNOWSKI JAMES J JAGX Common Stock M - Exercise D 13.133 73.765
2022-05-18 2022-05-18 4 Siegel Jonathan B. JAGX Restricted stock units M - Exercise D -12.133 0
2022-05-18 2022-05-18 4 Siegel Jonathan B. JAGX Common Stock M - Exercise D 12.133 12.133
2022-05-18 2022-05-18 4 DIVIS GREG J JAGX Restricted stock units M - Exercise D -12.133 0
2022-05-18 2022-05-18 4 DIVIS GREG J JAGX Common Stock M - Exercise D 12.133 12.133
2022-05-18 2022-05-18 4 MICEK JOHN JAGX Restricted stock units M - Exercise D -12.133 0
2022-05-18 2022-05-18 4 MICEK JOHN JAGX Common Stock M - Exercise D 12.133 12.133
2022-04-06 2022-04-05 4 Chaturvedi Pravin R JAGX Restricted stock units A - Award D 3.333 6.666
2022-04-06 2022-04-05 4 Chaturvedi Pravin R JAGX Common Stock M - Exercise D 3.333 3.333
2022-04-06 2022-04-05 4 Lizak Carol R. JAGX Restricted stock units A - Award D 4.513 9.028
2022-04-06 2022-04-05 4 Lizak Carol R. JAGX Common Stock M - Exercise D 4.513 12.481
2022-04-06 2022-04-05 4 Wolin Jonathan S. JAGX Restricted stock units A - Award D 6.666 13.333
2022-04-06 2022-04-05 4 Wolin Jonathan S. JAGX Common Stock M - Exercise D 6.666 6.666
2022-04-06 2022-04-05 4 CONTE LISA A JAGX Restricted stock units A - Award D 45.000 90.000
2022-04-06 2022-04-05 4 CONTE LISA A JAGX Common Stock M - Exercise D 45.000 53.003
2022-04-06 2022-04-05 4 King Steven R. JAGX Restricted stock units A - Award D 13.333 26.666
2022-04-06 2022-04-05 4 King Steven R. JAGX Common Stock M - Exercise D 13.333 13.333
2022-03-30 2022-03-28 4 DIVIS GREG J JAGX Restricted stock units A - Award D 85.900 85.900
2022-03-30 2022-03-28 4 Siegel Jonathan B. JAGX Restricted stock units A - Award D 85.900 85.900
2022-03-30 2022-03-28 4 MICEK JOHN JAGX Restricted stock units A - Award D 85.900 85.900
2022-03-30 2022-03-28 4 BOCHNOWSKI JAMES J JAGX Restricted stock units A - Award D 96.015 96.015
2022-03-30 2022-03-28 4 Chaturvedi Pravin R JAGX Restricted stock units A - Award D 195.934 195.934
2022-03-30 2022-03-28 4 Lizak Carol R. JAGX Restricted stock units A - Award D 97.025 97.025
2022-03-30 2021-09-13 4 Lizak Carol R. JAGX Common Stock P - Purchase I 2,5100 7.968 20 7.968
2022-03-30 2022-03-28 4 Wolin Jonathan S. JAGX Restricted stock units A - Award D 196.018 196.018
2022-03-30 2022-03-28 4 King Steven R. JAGX Restricted stock units A - Award D 137.685 137.685
2022-03-30 2022-03-28 4 CONTE LISA A JAGX Restricted stock units A - Award D 25.000 25.000
2022-03-30 2022-03-28 4 CONTE LISA A JAGX Restricted stock units A - Award D 606.280 606.280
2022-03-30 2021-09-13 4 CONTE LISA A JAGX Common Stock P - Purchase D 2,5100 7.968 20 8.003
2021-06-07 2021-06-04 4 BOCHNOWSKI JAMES J JAGX Common Stock S - Sale D 1,7400 -152 -0 954.390
2021-06-07 2021-06-03 4 BOCHNOWSKI JAMES J JAGX Common Stock S - Sale D 1,7500 -292 -1 954.542
2021-05-20 2021-05-18 4 Siegel Jonathan B. JAGX Restricted stock units A - Award D 36.400 36.400
2021-05-20 2021-05-18 4 Siegel Jonathan B. JAGX Stock option (right to buy) A - Award D 1,24 72.750 72.750
2021-05-20 2021-05-18 4 MICEK JOHN JAGX Restricted stock units A - Award D 36.400 36.400
2021-05-20 2021-05-18 4 MICEK JOHN JAGX Stock option (right to buy) A - Award D 1,24 72.750 72.750
2021-05-20 2021-05-18 4 DIVIS GREG J JAGX Restricted stock units A - Award D 36.400 36.400
2021-05-20 2021-05-18 4 DIVIS GREG J JAGX Stock option (right to buy) A - Award D 1,24 72.750 72.750
2021-05-20 2021-05-18 4 BOCHNOWSKI JAMES J JAGX Restricted stock units A - Award D 39.400 39.400
2021-05-20 2021-05-18 4 BOCHNOWSKI JAMES J JAGX Stock option (right to buy) A - Award D 1,24 78.750 78.750
2021-04-07 2021-04-05 4 Lizak Carol R. JAGX Restricted stock units A - Award D 40.625 40.625
2021-04-07 2021-04-05 4 Lizak Carol R. JAGX Stock option (right to buy) A - Award D 1,99 81.250 81.250
2021-04-07 2021-04-05 4 Wolin Jonathan S. JAGX Restricted stock units A - Award D 60.000 60.000
2021-04-07 2021-04-05 4 Wolin Jonathan S. JAGX Stock option (right to buy) A - Award D 1,99 120.000 120.000
2021-04-07 2021-04-05 4 King Steven R. JAGX Restricted stock units A - Award D 120.000 120.000
2021-04-07 2021-04-05 4 King Steven R. JAGX Stock option (right to buy) A - Award D 1,99 240.000 240.000
2021-04-07 2021-04-05 4 CONTE LISA A JAGX Restricted stock units A - Award D 405.000 405.000
2021-04-07 2021-04-05 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 1,99 810.000 810.000
2020-03-25 2020-03-20 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 0,45 45.486 45.486
2020-03-24 2020-03-20 4 Lizak Carol R. JAGX Stock Option (right to buy) A - Award D 0,45 50.000 50.000
2020-03-24 2020-03-20 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,45 79.431 79.431
2020-03-24 2020-03-20 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 0,45 26.533 26.533
2020-03-24 2020-03-20 4 Siegel Jonathan B. JAGX Stock Option (right to buy) A - Award D 0,45 45.486 45.486
2020-03-24 2020-03-20 4 Wolin Jonathan S. JAGX Stock Option (right to buy) A - Award D 0,45 59.753 59.753
2020-03-24 2020-03-20 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,45 238.293 238.293
2020-03-24 2020-03-20 4 DIVIS GREG J JAGX Stock option (right to buy) A - Award D 0,45 26.533 26.533
2019-07-26 2019-07-24 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 1,73 347.351 347.351
2019-07-26 2019-07-24 4 DIVIS GREG J JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 JOHNSON JEFFERY C. JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 MacNaughtan Murray David JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 1,73 121.573 121.573
2019-07-26 2019-07-24 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 1,73 303.932 303.932
2019-07-25 2019-07-24 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 1,73 1.042.052 1.042.052
2019-07-25 2019-06-07 4 CONTE LISA A JAGX Bridge Warrant to Purchase Common Stock P - Purchase D 2,00 37.500 37.500
2019-07-25 2019-07-24 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 1,73 208.410 208.410
2019-07-25 2019-07-23 4 BOCHNOWSKI JAMES J JAGX Series 1 Warrant to Purchase Common Stock P - Purchase I 2,00 180.582 180.582
2019-07-25 2019-07-23 4 BOCHNOWSKI JAMES J JAGX Series 2 Warrant to Purchase Common Stock P - Purchase I 2,00 180.582 180.582
2019-07-25 2019-07-23 4 BOCHNOWSKI JAMES J JAGX Common Stock P - Purchase I 2,0000 180.582 361 181.618
2019-07-25 2019-05-24 4 BOCHNOWSKI JAMES J JAGX Bridge Warrant to Purchase Common Stock P - Purchase I 2,00 218.750 218.750
2019-07-25 2019-07-24 4 Siegel Jonathan B. JAGX Stock Option (right to buy) A - Award D 1,73 208.410 208.410
2019-07-25 2019-07-23 4 Siegel Jonathan B. JAGX Series 1 Warrant to Purchase Common Stock P - Purchase I 2,00 12.705 12.705
2019-07-25 2019-07-23 4 Siegel Jonathan B. JAGX Series 2 Warrant to Purchase Common Stock P - Purchase I 2,00 12.705 12.705
2019-07-25 2019-07-23 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 2,0000 12.705 25 13.276
2019-07-25 2019-05-31 4 Siegel Jonathan B. JAGX Bridge Warrant to Purchase Common Stock P - Purchase I 2,00 34.375 34.375
2019-03-15 2019-03-14 4 Sagard Capital Partners, L.P. JAGX Series A Convertible Participating Preferred Stock P - Purchase I 0,28 5.524.926 5.524.926
2019-03-15 2019-03-14 4 Sagard Capital Partners, L.P. JAGX Series A Convertible Participating Preferred Stock H - Other I 2,78 -5.524.926 0
2018-10-24 2018-09-25 4 Nantucket Investments Ltd JAGX Non-Voting Common Stock S - Sale D 1,8300 270.270 495 38.180.451
2018-10-24 2018-09-25 4 Nantucket Investments Ltd JAGX Common Stock S - Sale D 1,8300 -325.615 -596 0
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 JAGX Common Stock I 2.916.667
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-12 3 Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC JAGX Common Stock I 2.083.334
2018-10-05 2018-10-04 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 0,6000 25.000 15 40.000
2018-10-04 2018-07-17 4/A Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,1900 268 0 15.000
2018-09-25 2018-09-25 4 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock G - Gift I -60.000 720.405
2018-08-03 3 GLASER JONATHAN M By JLA Family Limited Partnership JAGX Common Stock I 938.953
2018-08-03 3 GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan JAGX Common Stock I 1.018.001
2018-08-03 3 GLASER JONATHAN M By JLA Family Limited Partnership JAGX Common Stock I 938.953
2018-08-03 3 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock I 1.692.858
2018-08-03 3 GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan JAGX Common Stock I 1.018.001
2018-08-03 3 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock I 1.692.858
2018-08-03 3 GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan JAGX Common Stock I 1.018.001
2018-08-03 3 GLASER JONATHAN M By JLA Family Limited Partnership JAGX Common Stock I 938.953
2018-08-03 3 GLASER JONATHAN M By Pacific Capital Management, LLC JAGX Common Stock I 1.692.858
2018-07-20 2018-07-18 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,0952 5.000 5 14.732
2018-07-18 2018-07-18 4 CONTE LISA A JAGX Common Stock P - Purchase D 1,1124 1.500 2 7.500
2018-07-18 2018-07-17 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,1900 2.232 3 9.732
2018-07-18 2018-07-16 4 Siegel Jonathan B. JAGX Common Stock P - Purchase I 1,3586 7.500 10 9.732
2018-07-13 2018-07-11 4 MacNaughtan Murray David JAGX Stock Option (right to buy) A - Award D 1,36 104.860 104.860
2018-07-13 2018-07-11 4 DIVIS GREG J JAGX Stock Option (right to buy) A - Award D 1,36 104.860 104.860
2018-06-06 2018-03-12 4 Qiu Jiahao JAGX Stock Option (right to buy) A - Award D 8,40 12.965 12.965
2018-06-06 2018-03-12 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 8,40 53.164 53.164
2018-06-06 2018-03-12 4 Yang Zhi JAGX Stock Option (right to buy) A - Award D 8,40 12.965 12.965
2018-06-06 2018-03-12 4 Azhir Ari JAGX Stock Option (right to buy) A - Award D 8,40 39.286 39.286
2018-06-06 2018-06-01 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 2,73 85.854 85.854
2018-06-06 2018-06-01 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 2,73 149.311 149.311
2018-06-06 2018-06-01 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 2,39 251.665 251.665
2018-06-06 2018-03-12 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 8,40 71.709 71.709
2018-06-06 2018-06-01 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 2,39 146.804 146.804
2018-06-06 2018-03-12 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 8,40 38.643 38.643
2018-06-06 2018-06-01 4 Siegel Jonathan B. JAGX Stock Option (right to buy) A - Award D 2,73 104.860 104.860
2018-06-06 2018-06-01 4 JOHNSON JEFFERY C. JAGX Stock Option (right to buy) A - Award D 2,73 104.860 104.860
2018-06-06 2018-06-01 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 2,73 447.935 447.935
2018-03-14 2018-03-12 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,56 3.247.242 3.247.242
2018-03-14 2018-03-12 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 0,56 998.857 998.857
2018-03-14 2018-03-12 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,56 1.327.881 1.327.881
2017-12-29 2017-12-21 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,12 285.807 285.807
2017-12-29 2017-12-21 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,12 95.269 95.269
2017-12-29 2017-12-21 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 0,12 54.295 54.295
2017-08-09 3 Nantucket Investments Ltd JAGX Common Stock, par value $0.0001 per share ("Common Stock") D 9.768.490
2017-08-09 3 Nantucket Investments Ltd JAGX Common Stock, par value $0.0001 per share ("Common Stock") D 9.768.490
2017-08-09 3 Nantucket Investments Ltd JAGX Common Stock, par value $0.0001 per share ("Common Stock") D 9.768.490
2017-08-02 2017-06-28 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock P - Purchase I 0,5000 100.000 50 797.935
2016-12-21 2016-12-19 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 0,74 16.998 16.998
2016-12-21 2016-12-19 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 0,74 16.378 16.378
2016-12-21 2016-12-19 4 MICEK JOHN JAGX Stock Option (right to buy) A - Award D 0,74 10.884 10.884
2016-12-21 2016-12-19 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 0,74 2.866 2.866
2016-12-21 2016-12-19 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 0,74 4.496 4.496
2016-12-21 2016-12-19 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 0,74 13.771 13.771
2016-12-21 2016-12-19 4 Waltzman Roger J. JAGX Stock Option (right to buy) A - Award D 0,74 2.866 2.866
2016-11-14 2016-08-12 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 1,47 50.000 50.000
2016-09-26 2016-09-22 4 King Steven R. JAGX Stock Option (right to buy) A - Award D 1,25 23.042 23.042
2016-09-26 2016-09-22 4 Kamphuis Folkert W. JAGX Stock Option (right to buy) A - Award D 1,25 13.000 13.000
2016-09-23 2016-09-22 4 CONTE LISA A JAGX Stock Option (right to buy) A - Award D 1,25 318.000 318.000
2016-09-23 2016-09-22 4 Wright Karen Steil JAGX Stock Option (right to buy) A - Award D 1,25 103.698 103.698
2016-09-23 2016-09-22 4 BOCHNOWSKI JAMES J JAGX Stock Option (right to buy) A - Award D 1,25 75.000 75.000
2016-08-16 2016-08-12 4 Waltzman Roger J. JAGX Stock Option (right to buy) A - Award D 1,47 127.500 127.500
2016-06-16 2016-06-14 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 1,58 69.970 69.970
2016-06-16 2016-06-14 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 4,84 113.212 113.212
2016-06-16 2016-06-14 4 CONTE LISA A JAGX Stock option (right to buy) A - Award D 5,09 85.616 85.616
2016-06-16 2016-06-14 4 BOCHNOWSKI JAMES J JAGX Stock option (right to buy) A - Award D 1,58 11.293 11.293
2016-06-16 2016-06-14 4 Wright Karen Steil JAGX Stock option (right to buy) A - Award D 1,58 3.802 3.802
2016-06-16 2016-06-14 4 Qiu Jiahao JAGX Stock option (right to buy) A - Award D 1,58 1.901 1.901
2016-06-16 2016-06-14 4 King Steven R. JAGX Stock option (right to buy) A - Award D 1,58 28.263 28.263
2016-06-16 2016-06-14 4 King Steven R. JAGX Stock option (right to buy) A - Award D 5,09 49.942 49.942
2016-06-16 2016-06-14 4 Yang Zhi JAGX Stock option (right to buy) A - Award D 1,58 1.901 1.901
2016-06-16 2016-06-14 4 Kamphuis Folkert W. JAGX Stock option (right to buy) A - Award D 1,58 9.504 9.504
2016-04-05 2016-04-01 4 Brianceau Philippe JAGX Stock Option (right to buy) A - Award D 1,58 20.000 20.000
2016-02-09 2016-02-08 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock P - Purchase I 2,5000 160.000 400 487.576
2015-06-04 2015-06-02 4 BOCHNOWSKI JAMES J JAGX Stock option (right to buy) A - Award D 6,70 20.000 20.000
2015-06-04 2015-06-02 4 Qiu Jiahao JAGX Stock option (right to buy) A - Award D 6,70 10.000 10.000
2015-06-04 2015-06-02 4 Yang Zhi JAGX Stock option (right to buy) A - Award D 6,70 10.000 10.000
2015-06-04 2015-06-02 4 Kamphuis Folkert W. JAGX Stock option (right to buy) A - Award D 6,70 50.000 50.000
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Convertible Promissory Note C - Conversion I 5,60 0
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Series A Preferred Stock C - Conversion I -224.499 0
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Convertible Promissory Note C - Conversion I 5,60 0
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock C - Conversion I 5,6000 44.642 250 327.576
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock C - Conversion I 5,6000 35.714 200 282.934
2015-05-18 2015-05-18 4 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock C - Conversion I 148.332 247.220
2015-05-18 2015-05-18 4 Kallassy John A JAGX Stock Option (right to buy) A - Award D 7,00 13.365 13.365
2015-05-18 2015-05-18 4 Yang Zhi By Kunlun Pharmaceuticals, Ltd. JAGX Series A Preferred Stock C - Conversion I -2.224.991 0
2015-05-18 2015-05-18 4 Yang Zhi JAGX Common Stock C - Conversion I 1.483.326 1.522.881
2015-05-18 2015-05-18 4 BVCF Management, Ltd. By Kunlun Pharmaceuticals, Ltd. JAGX Series A Preferred Stock C - Conversion I -2.224.991 0
2015-05-18 2015-05-18 4 BVCF Management, Ltd. JAGX Common Stock C - Conversion I 1.483.326 1.522.881
2015-05-18 2015-05-18 4 Hauser Michael JAGX Stock Option (right to buy) A - Award D 7,00 73.000 73.000
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BVCF III-A, L.P. By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 NAPO PHARMACEUTICALS INC JAGX Common Stock D 5.333.332
2015-05-13 3 NAPO PHARMACEUTICALS INC JAGX Common Stock D 5.333.332
2015-05-13 3 Yang Zhi By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 Yang Zhi By Sichuan Biopharma JAGX Common Stock I 79.110
2015-05-13 3 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock I 197.776
2015-05-13 3 BOCHNOWSKI JAMES J By Bochnowski Family Trust JAGX Common Stock I 197.776
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)
Other Listings
DE:1JA0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista